Results
1 -
10 of
19
(Click
here to explore results)
- Chemical epigenetics to assess the role of HDAC1–3 inhibition in macrophage pro-inflammatory gene expression. Maria E. Ourailidou, Niek G. J. Leus, Kim Krist, Alessia Lenoci, Antonello Mai, Frank J. Dekker
, Med. Chem. Commun.
, 2016
, 7
, 2184
- A ‘click’ chemistry approach to novel entinostat (MS-275) based class I histone deacetylase proteolysis targeting chimeras. Jasmine M. Cross, Megan E. Coulson, Joshua P. Smalley, Wiktoria A. Pytel, Ozair Ismail, Justin S. Trory, Shaun M. Cowley, James T. Hodgkinson
, RSC Med. Chem.
, 2022
, 13
, 1634
- The effect of metalloprotein inhibitors on cellular metal ion content and distribution. Yao Chen, Barry Lai, Zhenjie Zhang, Seth M. Cohen
, Metallomics
, 2017
, 9
, 250
- Development of an advanced nanoformulation for the intracellular delivery of a caspase-3 selective activity-based probe. Francesco Cogo, Marcin Poreba, Wioletta Rut, Katarzyna Groborz, Peter Smyth, Michael C. Johnston, Richard Williams, Daniel B. Longley, Roberta E. Burden, Guy S. Salvesen, Marcin Drag, Christopher J. Scott
, Nanoscale
, 2019
, 11
, 742
- Histone deacetylase inhibitors for the treatment of cancer stem cells. M. Dvorakova, T. Vanek
, Med. Chem. Commun.
, 2016
, 7
, 2217
- Expanding the “minimalist” small molecule tagging approach to different bioactive compounds. Wenjie Lang, Chaonan Yuan, Biwei Zhu, Sijun Pan, Jian Liu, Jie Luo, Shikun Nie, Qing Zhu, Jun-Seok Lee, Jingyan Ge
, Org. Biomol. Chem.
, 2019
, 17
, 3010
- Photocontrolled activation of small molecule cancer therapeutics. M. Michael Dcona, Koushambi Mitra, Matthew C. T. Hartman
, RSC Med. Chem.
, 2020
, 11
, 982
- A combined approach for the study of histone deacetylase inhibitors. Lenka Činčárová, Gabriela Lochmanová, Kateřina Nováková, Pavla Šultesová, Hana Konečná, Lenka Fajkusová, Jiří Fajkus, Zbyněk Zdráhal
, Mol. BioSyst.
, 2012
, 8
, 2937
- Chimerically designed HDAC- and tyrosine kinase inhibitors. A series of erlotinib hybrids as dual-selective inhibitors of EGFR, HER2 and histone deacetylases. Thomas Beckers, Siavosh Mahboobi, Andreas Sellmer, Matthias Winkler, Emerich Eichhorn, Herwig Pongratz, Thomas Maier, Thomas Ciossek, Thomas Baer, Gerhard Kelter, Heinz-Herbert Fiebig, Mathias Schmidt
, Med. Chem. Commun.
, 2012
, 3
, 829
- Development of second generation epigenetic agents. Philip Jones
, Med. Chem. Commun.
, 2012
, 3
, 135